Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

DAURISMO™ Drug Interactions (glasdegib)

7 DRUG INTERACTIONS

Table 5. Drug Interactions with DAURISMO
Strong CYP3A Inhibitors
Clinical Impact
Prevention or Management
  • Consider alternative therapies that are not strong CYP3A4 inhibitors during treatment with DAURISMO.
  • Monitor patients for increased risk of adverse reactions including QTc interval prolongation [see Warnings and Precautions (5.2)].
Strong and Moderate CYP3A Inducers
Clinical ImpactCo-administration of DAURISMO with strong and moderate CYP3A inducers decreased glasdegib plasma concentrations [see Clinical Pharmacology (12.3)].
  • Decreased glasdegib concentrations may reduce efficacy.
Prevention or Management
  • Avoid co-administration of DAURISMO with strong and moderate CYP3A4 inducers.
  • If co-administration of DAURISMO with moderate CYP3A4 inducers cannot be avoided, increase the dose of DAURISMO [see Dosage and Administration (2.3)].
QTc Prolonging Drugs
Clinical ImpactCo-administration of DAURISMO with QTc prolonging drugs may increase the risk of QTc interval prolongation [see Warnings and Precautions (5.2)].
Prevention or Management
  • Avoid co-administration of QTc prolonging drugs with DAURISMO or replace with alternative therapies.
  • If co-administration of a QTc prolonging drug is unavoidable, monitor patients for increased risk of QTc interval prolongation [see Warnings and Precautions (5.2)].
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event